Focused Issue on Heart Failure Update and Advances in 2020

Posted On 2020-02-28 05:53:43



This Focused Issue on “Heart Failure Update and Advances in 2020” is edited by Dr. Debabrata Mukherjee and Dr. Jose Benjamin Cruz Rodriguez.

Debabrata Mukherjee, MD
Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA

Debabrata Mukherjee, M.D, is the Chairman of the Department of Internal Medicine at the Texas Tech University Health Sciences Center and Chief of Cardiovascular Medicine. Prior to this, he had held the position of the Gill Foundation Professor of Interventional Cardiology, Professor of Internal Medicine, and the Director of the Cardiac Catheterization Laboratory at the University of the Kentucky and the Director of the Peripheral Interventional Program at the University of Michigan. Dr. Mukherjee completed his residency training in Internal Medicine at the Cleveland Clinic Foundation. Subsequently he completed a fellowship in Cardiovascular Medicine and Interventional Cardiology also at the Cleveland Clinic Foundation. Dr. Mukherjee also completed a Masters in Clinical Research (MS) at the University of Michigan and a Certificate in Business Administration at the University Of Kentucky Gatton College Of Business. He presently serves on several journal editorial boards, is the Editor-in-Chief of the Cardiovascular and Hematological Agents in Medicinal Chemistry, and the Cardiology Reviews. In addition to being a long-standing fellow of the American College of Cardiology and the American Heart Association, he is a fellow of the Society for Vascular Medicine & Biology, Society for Cardiac Angiography and Interventions, and the International College of Angiology.

Jose Benjamin Cruz Rodriguez, MD
Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA

Benjamin Cruz Rodriguez, M.D., was born and raised in Guatemala City, where he completed medical school as first of his class in the University San Carlos in Guatemala (USAC). He completed a research fellowship in Nutritional Epidemiology by the Central America and Panama Institute of Nutrition (INCAP by its Spanish acronym) in collaboration with the University of Michigan. During his residency in Internal Medicine in Methodist Dallas Medical Center, he functioned as chief resident during his senior year. Dr. Cruz Rodriguez also completed a Master in Public Health with emphasis in Epidemiology at Harvard University T.H. Chan School of Public Health.

Subsequently he completed an Advanced Heart Failure and Transplant fellowship at the University of Alabama at Birmingham, followed by a fellowship in Cardiovascular Medicine at Texas Tech University Health Sciences Center in El Paso TX, position that he currently holds serving also as Chief Fellow.

Dr. Cruz Rodriguez received the Young Achiever Award by the American College of Physicians (ACP), has published 14 peer reviewed articles and has presented in several national and international meetings. He is currently serving as guest reviewer for several journals and textbooks. His research interest includes cost-effectiveness analysis, left-ventricular mechanical support, right ventricular dysfunction after left-assisted ventricular devices (LVAD) and valvulopathies post LVAD.

Focused issue outline:

  1. Update in pharmacotherapy in heart failure with reduced ejection fraction
  2. Optimal Diuretic strategies in heart failure
  3. Current role of angiotensin receptor-neprilysin inhibitors
  4. Pharmacotherapy for transthyretin cardiac amyloid
  5. Management of intraventricular thrombus
  6. Antiplatelet and anticoagulation strategies on left ventricular assist device therapy
  7. Pulmonary vasodilator use on left assist device therapy
  8. The holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction